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  This paper is part of a series that provides the details behind the Bureau of 
Economic Analysis's (BEA) satellite account on research and development (R&D) 
activity.  In the current work, the focus is on the theoretical underpinnings and empirical 
implementation of the R&D price index used to construct real R&D output.  We examine 
four alternative price indexes.  For each, we lay out the theoretical assumptions needed 
for the approach to be valid and examine how well the approach works in practice.  We 
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The Bureau of Economic Analysis and the National Science Foundation are 
jointly working to produce estimates of the impact of treating R&D as investment in a 
satellite account for the U.S. economy.  This paper is one in a set of background papers 
detailing the concepts and methodology underlying the 2007 satellite account estimates.  
This paper describes and explains the price index used in the 2007 R&D satellite account 
to transform current dollar expenditures into real, or inflation-adjusted, gross domestic 
product (GDP). 
The ongoing methodological work for the R&D satellite account has two goals: 1) 
In the near term to produce reasonable and internally consistent estimates of the impact 
on GDP and other macroeconomic variables of the impact of treating R&D as investment 
in a satellite account format, and 2) to develop the conceptual framework, methodology, 
and data sources necessary to incorporate R&D expenditures as investment into BEA’s 
core accounts beginning in 2012.  
R&D investment expenditures in the satellite account have two components, the 
internal production of R&D output for the firm’s own use, and the purchase of R&D 
output from other firms.  The estimation goal of the R&D satellite account is to measure 
the direct effects of this R&D investment, that is to say, excluding any separate measure 
of spillovers or externalities which are captured in the core GDP but not separately 
distinguished.  For this reason, the magnitude of the impact that R&D investment would 
have on real GDP depends, in large part, on the price indexes used to deflate current 
dollar investment. Ideally, such deflation would be conducted with a price index in which  
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the components are R&D output prices that reflect market transactions.  Unfortunately 
such price data are unavailable to construct these R&D output price indexes directly.  
Consequently, four alternative methods which infer the change in price of R&D output 
are evaluated to produce measures of real R&D investment.  These are 1) a set of 
industry-specific residual intangible asset price indexes, essentially profit-based price 
indexes, 2) a set of thirteen detailed industry output price indexes from R&D intensive 
industries, 3) an aggregate R&D output price index that combines the thirteen detailed 
output price indexes, and 4) an aggregated input price index based on the price indexes of 
the inputs to the R&D production process.  After describing the each of the price indexes, 
a comparison of index levels is presented.   
For the 2007 R&D satellite account, the aggregate R&D output price index is 
used for the featured estimates of the NIPA-based component of the satellite account as 
well as for the detailed estimates shown in the GDP-by-Industry component of the 
satellite account.  Even though we preferred the residual intangible asset price index on 
theoretical grounds, the aggregate input price index is used because the residual 
intangible asset price index yielded results that were implausible for some industries.  By 
aggregating the detailed output prices, the measurement errors for individual industries 
offset.  Thus, the choice of the aggregate output price index is a second-best solution that 
reflects implementation challenges and data limitations.  
The use of the aggregate R&D output price index for the satellite account reflects 
the experimental nature of the current work on the concepts and methodologies for 
treating R&D expenditures as investment.  Its use is a departure from the standard 
method of forming a price index when market prices are unavailable; this standard  
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method is the input price index approach.  Indeed, if R&D expenditures were to be 
treated as investment in the national accounts today, the input price index approach 
would be used because it is a consistent, repeatable, and internationally comparable 
standard.  Despite its practicality, the input price index suffers from the disadvantage of 
not allowing for productivity changes in the production of R&D output.  Instead, the 
input price index only reflects the impact of inflation on the cost of performing R&D 
activity.  Consequently, using the input price index produces the unintuitive result that 
capitalizing R&D has little-to-no effect on real GDP.  By contrast, the aggregate R&D 
output price index allows us to obtain good approximation of how capitalizing R&D 
would impact the national accounts, even though we currently do not have R&D output 
price data. 
 
  The paper is organized as follows: Section 1 describes the theoretical approach 
underlying the construction of the alternative R&D price measures.  Section 2 provides 
an explanation of the construction of each alternative and the challenges involved in 
implementation.  Section 3 compares the price indexes and explains the rational for the 
selection of the featured index, and Section 4 concludes.  An appendix section provides 
tables of the price indexes and provides a diagram and explanation of the components of 
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1. Approaches to Price Indexes for R&D output and investment  
 
1.1 Residual intangible asset price index  
This index focuses on the price that an innovator would charge for his output, 
which is taken to be an idea.  Except for the input-price index, all the price indexes are 
based on a framework that defines R&D output as an idea.  Innovators produce ideas 
which are then sold to firms who incorporate these ideas into their products.  A main 
premise of this approach is the comparability of R&D ideas from one period to the next.  
This approach works best when considering “evolutionary” ideas that are marginal 
improvements to the existing state of knowledge.  These evolutionary ideas stand in 
contrast to “revolutionary” innovations which present dramatic improvements to the 
current technology.
1  As detailed below, under our approach the innovator sets the price 
of an idea equal to the increase in the downstream firm’s profits attributable to the R&D 
output.  From the downstream firm’s perspective, the acquisition of R&D output can be 




1 The distinction between evolutionary and revolutionary innovations is frequently made in studies of 
R&D.  For a thorough review of revolutionary innovations (a.k.a. general purpose technology innovations), 
see the chapter written by Boyan Jovanovic and Peter Rousseau in the forthcoming Handbook of Economic 
Growth v.1B.  Kenneth Arrow also distinguishes between drastic and non-drastic innovations in “Economic 
Welfare and the Allocation of Resources for Invention” (Rand Working Paper P-1856-RC, 1959).  
2 Our approach has the same flavor of the endogenous growth model developed by Philippe Aghion and 
Peter Howitt (for a review of some of their work, see chapter 2 of the Handbook of Economic Growth, 
v1A).  Because our focus is on the transaction between the innovator and the downstream firm, we also 
explicitly model both agents’ profit maximizing problems. In this respect, our work is also related to 
Arrow’s work cited above, because we model how R&D innovation can affect the marginal revenue and 
marginal cost curves of the downstream firm and investigate the resulting effects of equilibrium profits and 
prices.  
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We model the production of R&D output as a stochastic process that can require a 
long period of time.  We describe the innovator’s problem as a research program that 
aims to either improve the quality, or reduce the cost, of a good produced by a 
downstream firm.  Research within the pharmaceutical industry, for example, typically 
aims to improve the quality of treatment for diseases.  We assume that downstream firms 
have some market power, and so model the quality improvement gain as an outward shift 
in the marginal revenue curve for the downstream firm.  Similarly, we model the 
reduction in costs as a downward shift in the marginal cost curve for the downstream 
firm.  In the downstream market, suppose the current demand curve and production 
technology implies a marginal revenue curve MR(q;θ,γ) and a marginal cost curve 
MC(q;α,β), where q denotes the quantity produced.  The parameter θ shifts the marginal 
revenue curve while γ is a vector of all other parameters that characterize this function.  
Similarly, α is a shift parameter for the marginal cost curve, while β is vector of all other 
parameters. 
 
We model the influence of R&D output on the downstream market through the 
shift parameters of the marginal revenue and cost curves.  R&D output can be product-
innovative, we which interpret as in increase in θ.  Given θ1> θ0, we assume that 
MR(q;θ1,γ)>MR(q;θ0,γ) for all q>0.  Alternatively, R&D output can be process-
innovative, which we interpret as in increase in α.  Given α1>α0, we assume that 
MC(q;α1,β)<MC(q;α0,β) for all q>0.  Note that in both cases, the downstream firm will 
generate higher profits with the R&D innovation, either through stronger demand or 
lower costs of production.  
We assume the R&D process uses a sequence of labor, l, and capital, k, inputs is 
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  so that L represents the weighted sum of labor inputs over T1 periods.  K is similarly 
defined.  Following the literature on R&D productivity, the weights account for the 
possibility that inputs at various stages in the R&D process may have different effects on 
R&D outcomes.
3  This specification highlights the difficulties associated with measuring 
the rate of return for R&D, given the potentially long periods of time necessary to 
generate R&D output. 
 
Producing R&D output is uncertain.  We denote the probability of producing an 
R&D innovation that produces a θ1 greater than the current θ0 by  
   ), , , | ( 0 1 K L G θ θ
 
where G has the expected properties of being a non-decreasing function of L and K. 
Similarly, we denote the probability of generating an R&D idea that generates an α1 
greater than the existing α0 by 
   ), , , | ( 0 1 K L H α α
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3 For background on various weighting schemes used in the literature, see Chapter 2 in R&D and 
Productivity: The Econometric Evidence (1998) by Zvi Griliches. where H has the expected properties of being a non-decreasing function of L and K. 
 
We assume that the innovator has all the bargaining power when negotiating with 
the downstream firm over the sale of R&D output.  Let Π(θ,α,γ,β) be the net present 
value of profits of the downstream firm given the current product and technology (i.e. 
conditioning on the current marginal cost and marginal revenue curves).   The price of 
R&D output depends upon the change in the net present value of profits resulting from 
the incorporation of the R&D idea.  For an R&D idea that generates a θ1>θ0 and so 
improves product quality, the price of R&D is  
 
) 1 ( ). , , , ( ) , , , ( 0 0 0 1 & β γ α θ β γ α θ Π − Π = D R P
 
Because the innovator has monopoly power, we assume the innovator captures all the 
gains resulting from the R&D idea.  Similarly, for an R&D idea that generates an α1>α0 
and so improves the production process, the price of R&D is  
 
) 2 ( ). , , , ( ) , , , ( 0 0 1 0 & β γ α θ β γ α θ Π − Π = D R P
 
 
  Equation 1 demonstrates that the price of R&D output can be written as PR&D = 
P(θ1,θ0,α,γ,β).  This specification emphasizes how the price of an R&D idea depends both 
on how it compares to existing technology, θ1 versus θ0, and how the current new idea 
will compare with future innovations.  The parameter vectors γ and β incorporate 
 
   
 




Using the notation developed above, we can formally write down the innovator’s 
optimization problem.  Below, we write down the case where the R&D output is aimed at 
improving quality, but the case where R&D output is process-oriented is analogous.  The 
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where (w,r) are the rental rates of labor and capital, respectively and δ is the real interest 
rate.  The innovator also faces a participation constraint, which implies that only R&D 
projects that have positive expected profits are undertaken.  This participation constraint 
ensures that, in expectation, R&D projects leads to higher profits for the downstream 
firm. 
 
While we assume that innovators capture all the gains in the downstream firm’s 
profits, this assumption can be relaxed.  Innovators can be modeled as capturing any 
fraction of the increase in profits from the downstream firm.  Further, we have described 
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4 For more details on R&D depreciation, see “Measuring the Returns to R&D: The Depreciation Problem” 
by Bronwyn Hall, NBER working paper 13473 (October 2007) and references therein.  
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the case where the R&D innovator sells the innovation to the downstream firm.  An 
alternative case, which provides the same result, occurs when the R&D innovator rents or 
licenses the idea to the downstream firm.  To fully describe the innovator’s problem in 
this case, we would need to decompose the downstream firm’s net present value of 
profits, Π, into per period profits and define both the length of time the innovation will be 
in use, and the licensing agreement between the R&D innovator and the downstream 
firm. 
 
Further, we consider R&D innovations as incremental improvements to existing 
technology.  Alternatively, R&D innovations could result in new products that create 
markets where none had existed before.  For these cases, the same framework can be 
applied.  Rather than pricing the R&D output as a change in profits, the innovator 
extracts the discounted value of profits from the sale of the new product (or some fraction 
thereof).   
 
Lastly, the above framework considers the innovator and the downstream firm as 
two separate entities.  There is no reason, however, that the innovator could not be part of 
the downstream firm.  In this case, the above framework could be used to properly 
allocate an internal return to investing in R&D. 
 
As discussed above, solving the innovator’s problem implies that the price of 
R&D, the price of one idea, is characterized by PR&D = P(θ1,θ0,α,γ,β).  We use this 
relationship in taking the model to the data to construct R&D price indexes for each industry.  The residual intangible asset price index approximates the change in the price 
of R&D output by measuring the change in profits attributable to R&D over time.  We 
measure the downstream firm’s gain to using R&D through a two-step process.  First, in 
every period we compute the gain attributable to R&D as gross output minus 
intermediate inputs minus labor costs minus the return to physical capital.  Physical 
capital costs are calculated using an average rate of return to existing fixed capital, where 
the average rate of return is the interest rate on Moody’s BAA corporate bonds.  Second, 
we take a five year moving average of these R&D gains, which we denote as Π5yr(t).  We 
take this second step for two reasons.  First, there is often an implementation lag for firms 
acquiring R&D innovations.  Second, the price of R&D depends upon the future 
discounted value of revenue attributable to the R&D innovation (see equation 1).  Taking 
a five-year moving average addresses these timing concerns, and also ensures that we 
consider only longer term trends in the return to R&D.  
 
Because the five-year moving average serves as an approximation to the 
downstream firm’s gains from purchasing R&D, it allows us to construct a price index 
for R&D output.  Under this approach, the change in R&D output price between 2 
adjacent years is the 1 year change in the 5 year moving average.  Formally,  
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where the price relatives on the left hand side are elements of the R&D output price 
index.  We assume that λ is equal to 1 in our calculations, but acknowledge that this 
scaling factor could also be set to a positive number smaller, or larger than 1.  
 
There are a couple of limitations to this approach.  First, our measure of profits 
attributable to R&D, being a residual measure, likely contains the effects of non-R&D 
factors.  Second, this approach assumes that R&D ideas are comparable from period to 
period.  Considering that most innovations are marginal improvements and our approach 
is at an industry level, the assumption that R&D innovations are evolutionary does not 
seem severe.  But the arrival of a revolutionary innovation would introduce substantial 
measurement error.  Third, our specification in equation 4 assumes that λ is constant over 
time and that there is a linear relationship between the two ratios.  Although these 
assumptions may be incorrect for particular industries or episodes of major technological 
change, it would require additional analysis at the micro-data level to ascertain the 
validity of these assumptions. 
 
The residual intangible asset price index is based on a data-intensive approach 
that requires the computation of firm’s profits attributable to gains from R&D.  This 
approach depends on detailed data, which can be too demanding.  As described later (see 
section 2.1), for several R&D intensive industries, the resulting residual intangible asset 
price index was extraordinarily volatile and hence unbelievable.  These results lead us to 
consider an alternative, second-best approach.   
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1.2 Detailed industry price index 
  The detailed industry price index is this second-best approach, and it infers the 
change in the price of R&D output from the change in price of the downstream product.  
To establish the link between R&D output and downstream product prices, we build upon 
the framework described above.  In particular, we use the fact that the purchase price of 
R&D derives from the innovator’s optimization problem.  Recall, this purchase price 
reflects the intricacies of the R&D production function as well as expectations about the 
depreciation of the R&D idea and its rate of return to the downstream firm.  Establishing 
the connection between movements in the downstream market product’s price and the 
price of R&D, naturally, requires additional assumptions on the nature of R&D output. 
 
We define R&D output as product-innovation when it shifts the marginal revenue 
curve of the downstream firm.  In contrast, R&D output is labeled as process-innovation 
when it shifts the marginal cost curve of the downstream firm.  While R&D innovations 
raise the downstream firm’s profits, they have different effects on the downstream 
market-clearing price.  We continue to denote the downstream firm’s marginal revenue 
curve as MR(q;θ,γ) and assume that dMR/dθ >0, where successful R&D ideas increase 
the value of θ.  Holding all else constant, this increase in demand due to the R&D 
innovation leads to a rise in the equilibrium price of the downstream firm’s product.
5  
Because innovators capture a fixed proportion of the rents to implementing a R&D 
 
5 See Chapter 1 in The Theory of Industrial Organization by Jean Tirole (1998) for details on this general 
property of monopoly pricing. innovation, within this framework there is a positive relationship between the price of 
R&D product innovation and the price of the downstream industry’s product, or 
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where the industry subscript refers to the downstream market.   
 
Conversely, those process-innovations that shift the marginal-cost curve to the 
right result in a fall of the market-clearing price.  Recall that the downstream firm’s 
marginal cost curve is MC(q;α,β), where as before we assume that dMC/dα <0 and that 
R&D innovations increase the value of α.  Holding all else constant, increases in α, by 
shifting the downstream firm’s marginal cost curve outward, lower the equilibrium price.  
This result holds in very general settings where the firm’s marginal revenue curve is 
decreasing and the marginal cost curve is increasing.  Importantly, this relationship 
implies a negative relationship between the price of R&D output and the price of the 
downstream industry’s product; where 
[ ] ) 6 ( . ) 1 ( ) ( ) 1 ( ) ( ) & & − − − ∝ − − t P t P t P t P industry industry D R D R  
 
 
Consequently, process-oriented R&D innovations may have the opposite effect on 
downstream product prices relative to product-oriented innovations.  As such, it is 
important to identify which type of R&D innovation prevails in an industry.  
It is likely that in most industries, R&D innovations are a mix of process and 
product-oriented ideas.  We assume the majority of R&D innovations are product-
oriented, and so use equation 5 as the basis for our empirical work to derive a R&D 
output price index.  Mansfield, “Industrial R&D in Japan and the United States: A 
Comparative Study” (AEA Papers and Proceedings, 78, 2, 1988, p.224-228) supports our 
approach, because it also characterizes the majority of U.S. industrial R&D activity as 
product innovation. A 2006 IBM Global Business Services study  of the chief executive 
officers also found that the emphasis of corporate innovation was a third more likely to 
be directed toward new products, services, or markets compared with operational 
innovation that improved effectiveness and efficiency (Expanding the Innovation 
Horizon, The Global CEO Study 2006, page 12).   
 
Rewriting equation 5, we arrive at the equation used to construct the detailed 
industry price index, 
 




















where the price relatives on the left hand side are elements of the R&D output price 
index.  As with the residual intangible asset price index, we assume that the scaling factor 
λ is equal to 1. 
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The main limitation to this approach is the assumption that changes in the output 
price of the downstream industry largely reflect changes in the price of R&D, as opposed 
to changes in other factors.  Using the notation introduced above, we are assuming that 
the changes in the downstream industry’s price are largely coming from changes in θ, as 
opposed to changes in γ.  In addition, we assume the R&D output in product-innovative 
and so affects the downstream firm’s marginal revenue curve.  If, on the other hand, the 
majority of R&D innovation is process-oriented, then our approach makes incorrect 
inferences about the price of R&D output from changes in the price of industry output.  
Lastly, as with the residual intangible asset price approach, we assume that R&D ideas 
are comparable from period to period, a reflection that most innovations are marginal 
improvements upon existing technology.   
 
  Empirically, this detailed industry approach yielded credible price indexes for 
most R&D-intensive sectors.  For several industries, however, the resulting price indexes 
were implausible (see section 2), an outcome that is likely due to measurement error.  To 
reduce the effect of industry-idiosyncratic measurement error, we considered a third, 
aggregate approach. 
 
1.3 Aggregate R&D output price index 
This approach averages the individual industry price indexes constructed from the 
detailed industry approach.  This single index is then used as the R&D price index for 
each industry.  By averaging across industries, the measurement errors associated with 
industry detailed price indexes likely offset.  There are at least two sources of  
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measurement error that may be diminished by averaging.  First, individual industry price 
relatives contain measurement error as a result of our approximations.  For example, we 
assume there is a constant, linear relationship between the price relatives of R&D output 
and the downstream product.  Averaging price relative reduces some of this random 
noise.  Second, there is measurement error at the industry level.  Certain industries, for 
example, may have a substantial amount of process-innovation which would likely bias 
the estimated price relatives downwards.  Once again, averaging across industries would 
dampen the impact of this source of measurement error.  The resulting aggregate price 
index then presents us with a measure of the long-run change in the price of R&D, 
smoothing through idiosyncratic industry effects. 
 
Not surprisingly, an additional assumption is necessary to validate the averaging 
of the industry detailed price indexes.  This approach assumes there are common drivers 
in R&D productivity across industries.  As such, we assume there are strong correlations 
among R&D output prices across industries.   
   
  Mechanically, this approach constructs a single price index by using a Fisher-
weighted average of the output prices of the thirteen R&D-intensive industries, where the 
weights are the industry’s share of annual business investment in R&D.  For years prior 
to 1987, detailed industry investment measures are not available, and so this index uses a 
weighted average of the top five industry R&D performers in each year.  Here the 
weights are not based on investment, but rather expenditures for R&D performance.   
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    As with the detailed industry approach outlined above, a major limitation of the 
aggregate price index is the assumption that economy-wide, most R&D innovation is 
product-oriented.  Further, an important underlying assumption of the aggregate price 
index approach is that the underlying R&D production process is similar across the R&D 
intensive industries.  Under this premise, averaging across industries is advantageous 
because it potentially reduces the influence of measurement error.  If it is the case, 
however, that the R&D production process across industries is distinctly different, then 




1.4 Cost of R&D Approach 
  When transaction data are hard to obtain, a standard approach in the national 
accounts to measuring an output’s price change is to rely on input cost data.  The 
underlying assumption is that the price of R&D is a constant markup over marginal cost.  
Thus, changes in R&D prices reflect changes in input costs.  This approach is consistent 
with the way that prices for government and other hard to measure services are often 
estimated in the national accounts.  It is also the approach recommended by Mansfield
6 
and others for R&D price indexes, and has been widely used in recent efforts to produce 
R&D satellite accounts in other countries.  In the U.S. R&D satellite account, these price 
indexes are based on Fisher aggregation of detailed price indexes for the inputs used to 
 
6 Mansfield, Edwin, Anthony Romeo and Lorne Switzer, 1983. “R&D price indexes and real R&D 
expenditures in the United States.” Research Policy 12:  105 -112. 
 create R&D.  A well-known disadvantage of the input-cost approach, however, is its 
inability to account for productivity increases within the R&D production process.   
  An important use of input price indexes for R&D activity is to track changes over 
time in the cost of performing R&D.  For example, the Biomedical Research and 
Development Price Index (BRDPI),  estimated by the Government Division of the 
Bureau of Economic Analysis (BEA), is used by the National Institutes of Health (NIH) 
to assess the impact of changes in input prices for R&D on the funding for biomedical 
research by NIH and its contractors/grantees. Similarly, the Small Business Innovation 
Research program (SBIR) funds high-tech R&D projects, and also uses R&D input price 
indexes to assets the impact of inflation on their funding recipients.  
 
 
2. Details of the construction of various price indexes. 
 
  This section describes the calculation of the price indexes tested for the R&D 
satellite account.  In each case the price relatives (Pt/Pt-1) are chained together to create 
price indexes, which have been normalized to 100 in the base year, 2000, set to 100.  
 
2.1 Residual intangible asset price index    
 
  The residual intangible asset price index uses the change in industry gains or 
residual profits that are attributable to intangible expenditures as an estimate of the 
unobserved price index for R&D.  Using equation (4) we estimate: 
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  It is calculated as the change in the 5-year moving average of the industry’s gains 
from its intangibles.  Each year’s gain is calculated as total revenue less variable costs, 
R&D expenditures, and the user cost of the currently recognized capital stock, where the 
user cost is calculated with an average rate of return.  
 
  Industry total revenue data are measured as gross output (the market value of an 
industry’s production); these data are drawn from BEA’s GDP-by-industry series.
7 
Variable costs and the cost of R&D are measured as the sum of labor compensation and 
intermediate inputs; these variables are also drawn from BEA’s GDP-by-Industry series. 
Assuming that there are no holding gains for the capital assets, the user cost, u, times the 
quantity of the industry’s existing capital stock, K, simplifies to: 
 
K r P K u
t t * )] ( [ *
* δ + ≈      
This cost is calculated in two parts, current cost depreciation (P
tδK) and current cost 
capital stock (P
tK) times an average rate of return, where P
tr
tK is replaced with: 





Current cost depreciation and current cost net capital stock data are drawn from BEA’s 
Private Fixed Assets by Industry data.
8 The average rate of return is estimated with a 
BAA corporate bond rate from Moody’s Investors Service.
9  
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7 Source: GDP-by-Industry data: 1987-1997 data are from  GDPbyInd_VA_NAICS_47to97R.xls,   1997-
2004 data are from  GDPbyInd_VA_NAICS.XLS, both worksheets are accessed at: 
http://www.bea.gov/industry/gdpbyind_data.htm 
 
8 Source: Private Fixed Assets by Industry data, tables 3.4ES and 3.1ES: 
http://www.bea.gov/national/FA2004/SelectTable.asp#S3  




  These residual intangible asset price indexes are estimated at the most detailed 
level possible based on existing BEA data.  Because this level of aggregation is less 
detailed than the level of the current dollar R&D investment estimates for the R&D 
satellite account, only seven intangible residual asset price indexes are estimated. These 
seven indexes are applied to the thirteen detailed industries.  For example, a price index 
calculated for all chemical manufacturing is applied to both pharmaceutical and medicine 
manufacturing and to all other chemical manufacturing.  An eighth index is created for all 
other industry R&D investment.  Table A shows the aggregation level of the residual 
intangible asset price indexes.   
  
  
                                                                                                                                                
The estimated residual intangible asset price is a component of gross operating 
surplus, a broad profit-like measure that includes corporate profits, proprietors’ income, 
net current business transfer payments, and consumption of fixed capital.  For computer 
and electronic products manufacturing, motor vehicle-related manufacturing, and other 
transportation equipment manufacturing the volatility of gross operating surplus during 
the estimation period 1987-2004 resulted in negative values for the five-year moving 
average of intangible asset residual. Chart A shows gross operating surplus and the five-
year moving average of the intangible asset residual for the computer and electronic 
products manufacturing industry, where annual gross operating surplus itself becomes 
negative.  This pattern is also consistent with NIPA-reported measures of corporate 
 
 
9 Source: 2007 Economic Report of the President, Table B-73, accessed at: 
http://www.gpoaccess.gov/eop/2007/B73.xls  
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profits for the industry these industries, for example, profits are negative for the computer 
and electronic products industry between 2001 and 2004.
10   
 
  While taking the five-year moving average of the intangible asset residual 
smoothed out transitory negative values for some industries, for three of the seven 
detailed indexes, negative values persisted and complicated the price index calculation.  
Although negative profits or a negative residual due to intangible assets have a sensible 
economic interpretation, negative prices do not, necessitating special handling of these 
values.  The industries affected are computer and electrical manufacturing, motor vehicle 
and parts manufacturing, and other transportation equipment manufacturing. 
  The following steps were used to create the price relatives for the index:  
 
 
a)       Pt , Pt-1 >0  
The price relative is Pt /Pt-1. 
For example, if Pt =16,000 and Pt-1 = 8,000. 
The residual gain has doubled, and the price relative is 2 . 
 
 
b)  Pt , Pt-1 < 0, and |Pt| < |Pt-1|  
The price relative = 2- Pt /Pt-1 
For example, Pt =-8,000 and Pt-1 = -16,000 
The residual gain has risen from -16,000 to -8000, and the price relative increases 
proportionately to = 1.5  
 
 
c)  Pt , Pt-1 < 0, and |Pt| > |Pt-1|  
The price relative = (1/(Pt /Pt-1)) 
For example, Pt =-16,000 and Pt-1 = -8,000 
The residual gain has fallen from -8,000 to -16,000, and the price relative falls 




10 BEA corporate profit measures are based on IRS data, and industries are reported on a company basis. 




d)       Pt x Pt-1 < 0 
The price relative is undefined. 
Use linear interpolation for the undefined price relative and the two adjacent price 
relatives. 
 
  Appendix table A details these prices indexes for the years 1987-2004.  Values 
that are shown in bold were originally estimated as undefined (for example year 2000 for 
computer and electronic product manufacturing) and imputed using the procedure above.  
Values that are shown in italics were also imputed because they neighbored an undefined 
value and therefore produced an implausibly volatile price relative.  
 
2.2 Detailed industry price index 
 
  The detailed industry R&D output indexes are individual chain-type Fisher 
indexes of industry output prices.  The change in the price of R&D investment is 
approximated with changes in the downstream or R&D using industry’s output price. 
Using equation (7) we estimate:  
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Here commodity price indexes are combined to create industry-specific R&D output 
prices indexes.  Pg refers to the price for each commodity that an industry produces, and 
Qg   refers to quantities of each commodity, and summation index g refers to the separate 
components being aggregated. These commodity prices and quantities are drawn from 
BEA’s annual Input-Output account database.  
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  The detailed industry output price indexes are built using the same source data 
and methodology used by BEA to publish industry output price indexes and aggregated at 
a custom level of detail to match the featured R&D Satellite Account industries; thus 
their construction includes unpublished data from BEA’s Industry Accounts.
 11 Table B 
shows how the detailed industry output price indexes relate to currently published BEA 
indexes.  Appendix table B details these price indexes for the years 1987-2004. 
   For the period 1997-2004, the indexes are computed using detailed item output 
prices grouped by the industries reported in the R&D satellite account (thirteen R&D 
intensive industries plus an “all other” category).  In the Fisher formula above, the 
summation index g corresponds to various items produced by each of these reported 
industries.  For the period 1987-1997, the indexes are computed using 6-digit NAICS 
industry output prices grouped into the reported industries.  Here the summation index g 
corresponds to various 6-digit NAICS industries.   
Charts B and C compare the detailed output price index for pharmaceutical and medicine 
manufacturing, and for semiconductor manufacturing to the residual intangible asset 
price indexes for each industry’s R&D investment.  For pharmaceutical and medicine 
manufacturing, chart B, the residual intangible asset price index and the detailed output 
price index tell a similar story—a rising price index for the R&D investment and the 
R&D output that is consistent with the product innovation scenario described in Section 1 
of the paper.   
 
11 Industry output price indexes currently published by BEA’s Industry Accounts can be found at 
http://www.bea.gov/industry/ .  For more information on the detail prices used by the Industry Accounts, 
see the Survey of Current Business Article “Preview of the Comprehensive Revision of the Annual 
Industry Accounts” published March 2004.  That article can be found online at 
http://www.bea.gov/scb/pdf/2004/03March/0304IndustryAcctsV3.pdf .    For semiconductor manufacturing, Chart C, rapidly falling output prices from 
about 1990 forward suggest a different measure of real R&D output compared with the 
residual intangible asset price index for the broad computer manufacturing industry 
(includes semiconductor manufacturing).  One possible explanation for this is that 
semiconductor-related R&D investment prior to 1990 was primarily process-related 
rather than product-related, breaking the link between the price of the innovation and the 
price of the downstream product.  Another alternative explanation is that the residual 
intangible asset price index is reflecting influences other than the price of the R&D, such 
as the recent boom and cycle in technology industries. 
    
2.3 Aggregate R&D output price index 
  This approach, like the approach described above, infers the change in the price of 
R&D output from changes in the downstream output price.  Unlike the detailed industry 
price approach, however, this approach develops a single R&D investment price that is 
used across all industries.  The aggregate R&D output index is a weighted combination of 
the private industry downstream output prices described in section 2.2 . For the years 
1957-2004, the aggregate output index is a chain-type Fisher index.  Conceptually, the 
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Here Pi(t) refers to the price of the detailed industry’s output, and  Qi(t) refers to the 
industry’s quantity of R&D investment.   
 
   
 
26  Because the real quantities of each industry’s R&D investment are unobserved, 
we estimate the aggregate R&D price index by substituting industry R&D investment in 
current dollars,  Ei(t)  and E(t-1), for Pi(t)Qi(t) and Pi(t-1)Qi(t-1) respectively, where the 
subscript i indicate separate R&D intensive industries: 
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The numerator in the first term under the radical revalues (t-1) expenditures at 
period (t) prices. This type of aggregate index is sometimes called a “Fisher of Fishers” 
because the price indexes used for the revaluation are Fisher price indexes.  
   For the 1987-2004 period the current dollar measures in the Fisher formula 
represent industry R&D investment published in the 2007 R&D Satellite Account.  Using  
current dollar R&D investment by industry provides an annual updating of the weights;  
changes in the composition of R&D by industry are annually incorporated into the 
aggregate R&D output price index.    
  The thirteen industries comprising the index account for on average 64 percent of 
total R&D investment in the 1987-2004 period.  The largest R&D investing industries  
are pharmaceuticals, semiconductors, motor vehicles, and aerospace.  During the 1987-
2004 period, R&D investment of pharmaceuticals and semiconductor manufacturing 
grew rapidly, with investment in transportation equipment R&D lagging behind (table C).  
These four industries, along with computer manufacturing, exert a large influence on the 
aggregate index.  Computer-related manufacturing industries in general have experienced 
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rapidly falling output prices, and thus their impact on the index is relatively large.  The 
aggregate R&D output price index fell from 105 to 95.3 between 1997 and 2004 
(Appendix table A); the detailed price index for computers and peripheral equipment fell 
from 202.1 to 53.1 over the same period and the detailed output price index for 
semiconductor manufacturing fell from 200.5 to 69.4  (Appendix table B).  
  Because the industry investment series developed in the 2007 satellite account 
begins in 1987, for earlier years the data are not available for the detailed annual industry 
R&D investment weights.  For the 1957-1987 period, the current dollar measures in the 
Fisher formula represent industry R&D expenses rather than industry R&D investment.   
The output price data are made up almost exclusively by BLS producer price indexes 
(PPIs); the two exceptions being in professional and scientific instruments manufacturing 
and R&D in other non-manufacturing industries (see table D).  The industries included in 
the index during this period are the top five R&D-performing industries on a 2-digit 
Standard Industry Classification basis measured according to R&D expenditures.  The 
included industries are allowed to change on a year-to-year basis depending on which 
industries ranked highest in that given year.  Four industries are always among the top 
five: chemicals and allied products (SIC 28), industrial and commercial machinery and 
computer equipment (SIC 35), electrical equipment except computer equipment (SIC 36), 
and transportation equipment (SIC 37).  The fifth industry is generally professional and 
scientific instruments (SIC 38), though this industry is occasionally replaced by 
petroleum refining and extraction (SIC 13, 29) or other non-manufacturing industries.  
Transportation equipment manufacturing, followed by electrical equipment 
manufacturing, is the key drivers of the index.  Their importance, however, is eroded over  
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time by growth in other industries, especially growth in chemicals and machinery.  The 
top five industries account for on average 86 percent of total R&D expenditures during 
the period. For years before 1958, the growth rate of the index is set equal to that of the 
BEA deflator for private fixed investment in equipment and software due to the scarcity 
of industry prices and weights in earlier years.  Appendix table A shows the aggregate 




2.4 Aggregate Input Price Index   
    
The aggregate input price index for R&D output and investment provides a 
baseline for comparing the alternative price indexes.  For the R&D input price index, 
prices for the various R&D inputs are used to deflate nominal R&D output at the most 
detailed cost level possible.  Because the source data are performer-based, BEA first 
creates the input price indexes on a performer basis and aggregates them into an 
aggregate input price index. Using this aggregate input price index and two NIPA-based 
indexes for R&D funded by the Federal government, an index for non-Federal R&D 
purchases is derived residually.  This non-Federal aggregate input price index is used to 
deflate business, non-profit, and academic R&D investment.    
Unlike the detailed industry price indexes created in the residual intangible asset 
price index and the detailed output price index, all industry R&D investment is deflated 
with a single price index, rather than detailed industry R&D input price indexes.  Industry 
specific data on composition of materials and supplies used for R&D are not available by investing industry, and for the largest component of cost, wages and salaries for scientists 
and engineers, consistent time series by industry were not available. 
To create the performer-based indexes, expenditures and input price relatives are 
aggregated together using a Fisher chain-weighting process described in Equation (10) to 
generate total real R&D expenditures. The resulting aggregate input price index is 
calculated as:  
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Here expenditures with the subscript j are inputs to the R&D process, and the 
price relatives are the prices of each input. Table E lists the price indexes that are used to 
construct the aggregate input price index for input component for each performer.  
 For the aggregate business sector (private industry), BEA uses salaries for 
engineers in R&D organizations to deflate compensation costs for R&D personnel. 
Materials and supplies, overhead, and depreciation for business sector R&D are deflated 
using the input price indexes from costs incurred by the R&D services industry (NAICS 
5417).  These prices are based on detailed data for intermediate input costs available in 
BEA’s industry accounts. 
For R&D performed by colleges and universities, expenses for consumption of 
fixed capital (CFC) are deflated separately from all other expenses.  All non-CFC R&D 
expenses funded by the Department of Health and Human Services are deflated using a 
biomedical R&D price index that BEA developed for the National Institutes of Health.  
The remaining non-CFC academic R&D expenditures are deflated using an overall 
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academic R&D price series developed for the National Center for Education Statistics 
from 1960 to 1995.
 12  This overall R&D index is extrapolated for the other years based 
on the BEA price index for personal consumption expenditures on other education and 
research. 
The Federal sector uses a variety of NIPA price indexes for defense and non-
defense R&D-related costs such as compensation, intermediate purchases of goods and 
services, and investment in structures, equipment, and software. These performer-based 
input price indexes are used in conjunction with a national income and product account 
(NIPA) price index for total Federal defense and non-defense purchases of R&D and an 
internally developed price index for R&D performed by the Federal government in order 
to develop the input price indexes for each sector’s R&D investment.  
 To derive a price index for the remaining, non-Federally funded R&D, BEA uses 
the Federal price indexes described above and the overall (performer-based) price index 
to derive a residual index for non-Federally funded price index.  When the Federal price 
indexes are combined with this derived non-Federal funder index using a chain-type 
formula, the total funder-based price index matches the total performer-based index. 
Table A shows the aggregate R&D input price index for 1987-2004. 
 
3. Empirical Comparison of Price Indexes 
The price indexes discussed above provide substantially different measures of 
R&D output’s price change.  The input price index steadily increases from 1987 to 2004, 
with an average price increase of 2.5% at an annual rate.  In contrast, the aggregate 
 
12 National Center for Education Statistics, Digest of Education Statistics, 2004, Table 35.  
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output price index is relatively flat from 1987 to 1995, before declining from 1995 to 
2003 at an average rate of 2.8 percent (see chart D).   
The steady up-tick of the input price index highlights the limitations in using it as 
a deflator.  Starting in the late 1990’s, the US experienced a surge in productivity growth.  
This increase is most often attributed to the rapid technological progress and investment 
in the Information-Communications-Technology Producing industries.
13  Yet this 
explosion of activity in these R&D-intensive industries is not reflected in the input-cost 
price index, because the input-cost approach does not account for productivity increases 
in the R&D production process.  Rather, this index records steady price indexes, missing 
how the infusion of R&D investment that occurred in the late 1990’s likely influenced the 
price of R&D output.   
 
  In contrast to the input-price approach, the residual intangible asset price method 
focuses on measuring the downstream firm’s gain from using R&D.  Of the approaches 
discussed here, this approach most directly attempts to estimate the price of R&D output.  
The resulting set of price indexes, however, produced implausible estimates of R&D 
output price change in some industries.  For example, chart E plots the residual intangible 
asset price index for semiconductors and for other transportation-equipment 
manufacturing industries.  The extreme volatility of both these indexes signifies that this 
approach measures the price of R&D output with significant measurement error. 
 
 
13 See then-Governor Benjamin Bernanke’s February 24
th, 2005 speech, “Productivity”, presented at the 
University of Arkansas in Little Rock, Arkansas and references therein for details on the US’s surge in 
productivity growth.  
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  The limitations of the input price and residual intangible asset price indexes led to 
our choice of the aggregate price index for the 2007 R&D satellite account estimates.  It 
does not display excessive volatility.  Further, unlike the input-cost price index, the 
aggregate price index seems to reflect the changing dynamics of the R&D sector.  While 
relatively flat from 1987 to 1995, this index records a steady decline in the price of R&D 
output in the late 1990’s, concurrent with large increases in R&D investment. 
 
  The aggregate price index is preferred to the set of detailed industry price indexes 
primarily because several of the industry price indexes are quite volatile.  The detailed 
industry price index for semiconductors, for example, falls from over 500 to under 70 
from 1987 to 2004, where 2000 is the base year (chart C).  In these instances, the detailed 
industry price index is likely capturing other dynamics within the industry.  By averaging 
across industries, the aggregate price index downplays the influence of the more volatile 
detailed industry price indexes.  As detailed in section 1, we assume each detailed 
industry price index approximates the R&D output price index with measurement error.  
By taking the average, the aggregate price index should reduce the overall error, because 
there are likely off-setting errors that the averaging process combines.  Importantly, the 
detailed industry and aggregate price indexes will produce similar measures of real total 
R&D output.  These two approaches, however, produce different measures of industry-
level real R&D output. 
 
To uncover what is driving the movement in the aggregate price index, we chart 
the detailed industry price indexes for R&D output, of which the aggregate price index is  
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a weighted average (see section 1.3).  For our analysis, we categorize the R&D-intensive 
industries into 3 groups:  biotechnology industries, transportation-equipment 
manufacturing, and information-communications-technology (ICT) producing industries.  
According to the detailed industry price indexes, the first two groups of industries 
experienced steady price increases of R&D output from 1987 to 2004 (see charts F and 
G).  The price of pharmaceutical R&D output, for example, increased at an average 
annual rate of 4.8%.  In sharp contrast, most industries within the third group, the ICT 
industries, saw large and sustained decreases in the price of R&D output (see chart H and 
I).  This is particularly true for the semiconductor, software and computer and peripheral 
equipment industries.   
 
From 1987 to 1995, the weighted average of all detailed industry price indexes 
resulted in a flat aggregate price index, because increases in biotechnology and 
transportation equipment manufacturing industries were offset by decreases in software, 
semiconductors, and other ITC industries.  Recall however, that the weights used to 
construct the aggregate price index are updated each year based on R&D activity (see 
section 1.2).  In the 1990’s, the large surge in R&D activity within the ITC sector meant 
these industries received more weight within the aggregate industry price index.  Thus, 
from 1995 onwards, the aggregate price index tends to reflect R&D output price 
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4. Conclusion  
  Once the scope of included current dollar R&D expenditures is estimated, the 
choice of the deflator for R&D investment is the major determinant of the impact on 
GDP that results from the change in the national accounting treatment. The reason for 
this is that the R&D satellite account measures only the direct effects of treating R&D as 
investment, and excludes separate estimates of spillovers, which are included in core 
GDP, but not separately distinguished.   
  If R&D were to be incorporated as investment into the core accounts today, the 
choice for an R&D investment deflator would be an input price index that is typically 
used when there are no available output prices.  This alternative is consistent, repeatable, 
and internationally comparable, but it also substantially biases downward measures of 
R&D’s impact as investment in the national accounts because it misses productivity 
improvement in the production of R&D output.  For this reason, we have developed and 
tested a set of alternative price indexes for the 2007 R&D satellite account.   
   In the absence of observable market prices for R&D investment, we test three 
alternative approaches to the input price index.  Theoretically, we view the residual 
intangible asset price index as the correct one.  The price an innovator can command for 
an innovation is the discounted value of the gains that an investor will reap from using 
the innovation over a period of time.  Although the model is presented as one with an 
innovator selling its output, it is suitable for internally created R&D production.  In 
practice, the implementation of the residual profit price index provided implausible 
results for some industries, notably computer manufacturing and motor vehicle 
manufacturing.  In part, the reason for this result is that there are little data that would  
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allow for an isolation of the impact on downstream firm’s profit from the acquisition of 
the R&D output.   
  Accordingly, the attention was directed to where the price data exist--the 
downstream industries. This approach treats the movement of the downstream output 
prices as reflective of the R&D output price.  This approach is based on the following 
presumptions: 
•  U.S. R&D output is more oriented toward product improvement than process 
improvement. 
•  These exists a stable relationship between the movement of the downstream 
industry’s output prices and the prices of the R&D output that the industry 
purchases or creates for its own use.  
•  The impact of R&D on output prices dominates all other factors influencing the 
output price.  
   The implementation of these detailed output price indexes obtained a wide range 
of results that in part may derive from the measurement error associated with these 
presumptions. 
  Our choice of the aggregate R&D output price index for the 2007 satellite account 
in principal overcomes the impact of measurement error for the detailed industry 
estimates of real gross output and value added by allowing for offsetting errors.  
Aggregation gives a stable price index series.  Yet, the aggregation does not overcome 
the possibility that the relationship between movement of the output price of the 
downstream producer and the output price of the R&D producer may not be robust for all 
industries.    
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  Nevertheless, we show that the aggregate output price index for R&D investment 
provides a qualitatively different price trend from the practical alternative for the R&D 
satellite account estimates, the aggregate input price index for R&D investment.  The 
aggregate input price index is monotonically increasing, while the aggregate output price 
index falls notably in recent years.  In sum, the aggregate output price index, at this point, 
makes more sense then the alternatives.     
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Table A. Aggregation Level for Residual Intangible Asset Price Index 
Detail Level for Residual Intangible Asset 
 Price Index (NAICS code) 
Detail Level for Current dollar investment, gross output, and value added 
(NAICS code) 
Pharmaceutical and medicine manufacturing (3254)  Chemical Manufacturing  (325) 
Other chemical manufacturing (325 except 3254) 
Computer and peripheral equipment manufacturing (3341) 
Communication equipment manufacturing (3342) 
Semiconductor and other electronic component manufacturing (3344) 
Navigational, measuring, electro-medical, and control instrument manufacturing (3345) 
Computer and electronic products 
manufacturing (334) 
Other computer and electronic product manufacturing (3343, 3346) 
 Motor vehicles, bodies and trailers, and 
parts (3361-3363) 
Motor vehicle and motor vehicle and parts manufacturing (3361-3363) 
Aerospace products and parts manufacturing (3364)   Other transportation equipment (3364, 3365, 
3366, and 3369)  Other transportation equipment manufacturing (3365, 3366, 3369) 
Publishing industries (511)  Software publishers (5112) 
Computer systems design and related 
services  (5415) 
Computer systems design and related services (5415) 
Miscellaneous professional, scientific, and 
technical services (541), less Legal services 
(5411) and computer services (5415). 
Scientific R&D Services (5417) 
Special aggregate of all private industries,  
less agriculture, FIRE, and the detailed 
industries listed above 





























Table B. Currently Published BEA Output Price Indexes (boldface) and R&D Satellite 
Account Detail Output Price Sub-Indexes (standard) 
Industry NAICS 
Code 
Industry Output Price Index Series 
325
3254 
325 except 3254 
Chemical manufacturing 
Pharmaceutical and medicine manufacturing 








Computer and electronic product manufacturing 
Computer and peripheral equipment manufacturing 
Communication equipment manufacturing 
Semiconductor and other electronic components manufacturing 
Navigational, measuring, electro-medical, and control instruments    
  manufacturing 
Other computer and electronic products manufacturing 




Other transportation equipment manufacturing 
Aerospace products and parts manufacturing 
Other transportation equipment manufacturing 
511
5112 
Publishing (includes software) 
Software publishers 




Miscellaneous professional, scientific, and technical services 
 
Scientific research and development services 
Note 1: Asterisk (*) indicates that index series is both a currently-published output price index and one of 
the detail output price indexes featured in the satellite account. 
Note 2: There is also an  all other private industries output price index represents prices for all private 
industries excluding the 13 industries featured in the R&DSA.  




Table C. Share of Total R&D Investment, selected industries, 1987-2004 (percent) 
 1987-1994  1995-2004 
Pharmaceutical and medicine mfg (NAICS 3254)  9.4  12.4 
Computer and peripheral equipment mfg (NAICS 3341)  4.6  3.5 
Semiconductor mfg (NAICS 3344)  8.1  8.1 
Motor vehicles and parts mfg (NAICS 3361-3363)  10.9  10.0 
Aerospace products and parts mfg (NAICS 3364)  8.4  4.0 
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Table D. Industries Comprising Aggregate Output Price Index and Proxy Industry R&D 
Prices  
Industries Comprising 
Aggregate Output Price Index  Industry R&D Prices 
1987-2004 (NAICS) 
Pharmaceutical and medicine manufacturing (3254) 
Other chemical manufacturing (325 excluding 3254) 
Computer and peripheral equipment manufacturing   
        (3341) 
Communication equipment manufacturing (3342) 
Semiconductor and other electronic component  
        manufacturing (3344) 
Navigational, measuring, electro-medical, and control  
        instrument manufacturing (3345) 
Other electronic product manufacturing (3343 and   
        3346) 
Motor vehicle and motor vehicle and parts  
        manufacturing (3361-3363) 
Aerospace products and parts manufacturing (3364) 
Other transportation equipment manufacturing  
        (3365, 3366, and 3369) 
Software publishers (5112) 
Computer systems design and related services  
        (5415)  
Scientific research and development services (5417) 
Corresponding industry output 
prices used in the detail output 
index scenario. 
1957-1987 (SIC) 
Always among top 5 R&D performing industries 
Chemicals and allied products (28)  PPI for chemicals 
Industrial and commercial machinery and computer  
       equipment (35) 
PPI for machinery 
Electrical equipment except computer equipment   
       (36) 
PPI for electrical machinery and 
equipment 
Transportation equipment (37)  PPI for transportation equipment 
or PPI for motor vehicles 
Sometimes among top 5 R&D performers 
Professional and scientific instruments (38)  BEA deflator for private fixed 
investment in medical equipment 
and instruments 
Petroleum refining and extraction (SIC 13, 29)  PPI for petroleum products 
Non-manufacturing industries  BEA deflator for services exports 
1929-1957 (No Industry Detail Used) 
Index growth rate corresponds to growth rate of BEA deflator for private investment in equipment and 
software 
  




Table E. Input Price Indexes: Source Data and Methods for Cost Components and 
Corresponding Deflation 
Cost component  Data and methods for cost component  Method for deflation 
Private sector    Aggregate of input price detail for all 
privately-performed cost components. 
Business (industry)    For 1987-2004, aggregate of input price 
detail.  For 1959-86, R&D deflation is 
performed at the total business level using 
the GDP implicit price deflator (IPD). 
Compensation of R&D personnel  For 1987-2004, NSF reported distribution of 
wages of R&D personnel by industry. 
 
Scientists and engineers  For 1987-2004, based on 1987 detail from 
NSF working paper (Jankowski 1990
14). 
For 2000-04, judgmental estimates based 
on salaries for R&D scientists and 
engineers from R&D Magazine salary 
surveys and BEA’s unpublished chain-type 
Laspeyres salary index based on engineer 
salaries in R&D organizations from the 
American Association of Engineering 
Societies (AAES) annual salary surveys.  
For 1987-99, BEA’s unpublished chain-
type Laspeyres salary index based on 
AAES data.  
Support personnel  For 1987-2004, based on 1987 detail from 
NSF working paper (Jankowski 1990). 
BEA unpublished index based on BLS 
average hourly earnings of production 
workers in research and testing services. 
Materials and supplies  For 1987-2004, NSF reported distribution of 
R&D materials and supplies by industry. 
BEA unpublished composite index for 
materials in the scientific R&D services 
industry (NAICS industry 5417) from the 
KLEMS data in the annual industry 
accounts. 
Other R&D costs (overhead)  For 1987-2004, NSF reported distribution of 
R&D overhead costs by industry. 
BEA unpublished composite index for 
overhead in the scientific R&D services 
industry (NAICS industry 5417) from the 
annual industry accounts. 
Consumption of fixed capital (CFC) 
for structures and equipment 
To identify the CFC cost component: For 
2001-2004, NSF reported distribution of 
historical-cost depreciation.  For 1959-2000, 
NSF reported distribution of historical-cost 
depreciation for 2001 was use 
 
To adjust CFC to an economic basis: For 
1959-1987, historical-cost depreciation was 
adjusted to a current-cost basis using the ratio 
current-cost depreciation to historical-cost 
depreciation of assets used to perform R&D 
at private academic institutions.  For 1988-
2004, estimated by applying the NIPA CFC 
growth rates for total business. 
NIPA price index for depreciation in 
NAICS industry 5412. 
Federally funded research and 
development centers (FFRDCs) 
administered by business 
  Aggregate of input price detail 
                                                 
14 Jankowski, John, Jr. “Construction of a Price Index for Industrial R&D Inputs,” National Science 
Foundation Working Paper, August 1, 1990.   
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Table E. Input Price Indexes: Source Data and Methods for Cost Components and 
Corresponding Deflation 
Cost component  Data and methods for cost component  Method for deflation 
DOD- and NASA-funded FFRDCs  Weight of expenditures based on R&D 
obligations to industry-administered FFRDCs 
for the agencies that define the component. 
NIPA price index for Federal defense 
purchases of R&D services. 
HHS-funded FFRDCs  Weight of expenditures based on R&D 
obligations to industry-administered FFRDCs 
for the agencies that define the component. 
For 1979-2004, NIPA unpublished 
biomedical R&D price index.  For 1929-
1978, extrapolated by NIPA personal 
consumption expenditures price index for 
"other" education and research. 
DOE-funded FFRDCs and all other 
FFRDCs 
Weight of expenditures based on R&D 
obligations to industry-administered FFRDCs 
for the agencies that define the component. 
NIPA unpublished price index for Federal 
nondefense purchases of R&D services. 
Private universities and colleges    Aggregate of input price detail 
R&D expenditures excluding CFC 
HHS-funded 
Estimate of HHS-funded R&D expenditures 
less research equipment expenditures, which 
were removed from current expenses and 
reclassified as investment.  Based on HHS 
R&D obligations to academic performers.   
For 1979-2004, NIPA unpublished 
biomedical R&D price index for academic 
grants and contracts.  For 1929-1978, 
extrapolated by NIPA personal 
consumption expenditures price index for 
"other" education and research. 
R&D expenditures excluding CFC 
non-HHS-funded 
R&D expenditures less research equipment 
expenditures, which were removed from 
current expenses and reclassified as 
investment with HHS funded portion 
removed.   
For 1960-95, academic R&D price index 
from the National Center for Education 
Statistics.  For other years, extrapolated by 
NIPA personal consumption expenditures 
price index for "other" education and 
research. 
CFC for structures  Perpetual inventory calculations at current 
cost, based on gross investment and on 
investment prices.  Gross investment for 
R&D structures:  Calculated as a percent of 
total NSF reported science and engineering 
space through 1989 then extrapolated to 2004 
based on NIPA price index for gross 
government fixed investment in educational 
structures. 
Direct valuation: Perpetual inventory 
calculations based on gross investment and 
investment prices. 
Investment prices:  For structures, the 
NIPA index for private fixed investment in 
nonresidential structures by the educational 
services industry. 
CFC for equipment  Perpetual inventory calculations at current 
cost, based on gross investment and on 
investment prices.  Gross investment for 
R&D large equipment:  Calculated as a 
percent of total science and engineering 
space.  For small equipment: NSF reported 
current fund research equipment 
expenditures, which were removed from 
current expenses and reclassified as 
investment. 
Direct valuation: Perpetual inventory 
calculations based on gross investment and 
investment prices. 
Investment prices:  For equipment, the 
NIPA index for private fixed investment in 
equipment and software by the educational 
services industry (NAICS industry 61). 
Federally funded research and 
development centers (FFRDCs) 
administered by private universities 
and colleges 
  Aggregate of input price detail 
DOD- and NASA-funded FFRDCs 
excluding CFC 
Expenditures for each FFRDC aggregated by 
Federal sponsoring agency, less research 
equipment, which were removed from 
current expenses and reclassified as 
investment. 
NIPA price index for Federal defense 
purchases of R&D services.  
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Table E. Input Price Indexes: Source Data and Methods for Cost Components and 
Corresponding Deflation 
Cost component  Data and methods for cost component  Method for deflation 
DOE-funded FFRDCs and all other 
FFRDCs excluding CFC 
Expenditures for each FFRDC aggregated by 
Federal sponsoring agency, less research 
equipment, which were removed from 
current expenses and reclassified as 
investment. 
NIPA unpublished price index for Federal 
nondefense purchases of R&D services. 
CFC for structures and equipment  Perpetual inventory calculations at current 
cost, based on gross investment and on 
investment prices.  Gross investment for 
R&D structures and equipment:  Federal 
obligations on plant to FFRDCs administered 
by private universities and colleges and BEA 
estimated research equipment expenditures, 
which were removed from current expenses 
and reclassified as investment.   
Direct valuation: Perpetual inventory 
calculations based on gross investment and 
investment prices. 
Investment prices:  For equipment, the 
NIPA index for private fixed investment in 
equipment and software by the educational 
services industry (NAICS industry 61); for 
structures, the NIPA index for private fixed 
investment in nonresidential structures by 
the educational services industry. 
Other nonprofit institutions serving 
households 
Expenditures for years surveyed by NSF.  
For years where data are unavailable, Federal 
funding interpolated or extrapolated by 
Federal obligations to nonprofit institutions; 
non-Federal funding interpolated or 
extrapolated by personal consumption 
expenditures for foundations and nonprofit 
research. 
NIPA IPD for foundations and nonprofit 
research. 
Federally funded research and 
development centers (FFRDCs) 
administered by other nonprofit 
institutions serving households 
  Aggregate of input price detail 
DOD- and NASA-funded FFRDCs  For 2001-04, expenditures for each FFRDC, 
aggregated by Federal sponsoring agency 
categories.  For other years, Federal agency 
obligations to FFRDCs administered by other 
nonprofit institutions. 
NIPA price index for Federal defense 
purchases of R&D services. 
DOE-funded FFRDCs and all other 
FFRDCs 
For 2001-04, expenditures for each FFRDC, 
aggregated by Federal sponsoring agency 
categories.  For other years, Federal agency 
obligations to FFRDCs administered by other 
nonprofit institutions. 
NIPA unpublished price index for Federal 
nondefense purchases of R&D services. 
    
Government sector    Aggregate of input price detail for all 
government-performed R&D components. 
Federal Government  For 1929 to 1950, deflated at the aggregate 
Federal level.  For 1951 to 2004, see detail 
below. 
For 1929 to 1950, deflated in total using 
the average of the NIPA price indexes for 
defense and nondefense R&D services.  
For 1951 to 2004, aggregate of input price 
detail. 
Compensation of employees    Aggregate of input price detail 
DOD-funded R&D  Federal obligations to intramural R&D by 
agency and by cost type. 
For 1972-2004, NIPA IPD for Federal 
defense compensation of general 
government civilian employees.  For 1951-
1971, NIPA IPD for Federal defense 
compensation of general government 
employees (all). 
DOE funded R&D  Federal obligations to intramural R&D by 
agency and by cost type. 
NIPA IPD for Federal nondefense 
compensation of general government 
employees.  
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Table E. Input Price Indexes: Source Data and Methods for Cost Components and 
Corresponding Deflation 
Cost component  Data and methods for cost component  Method for deflation 
HHS-funded R&D  Federal obligations to intramural R&D by 
agency and by cost type. 
For 1979-2004, NIPA unpublished 
biomedical R&D personnel price index.  
For 1951-1978, extrapolated by NIPA IPD 
for Federal nondefense compensation of 
general government employees. 
NASA and other Federal agency 
funded R&D 
Federal obligations to intramural R&D by 
agency and by cost type. 
NIPA IPD for Federal nondefense 
compensation of general government 
employees. 
Materials and supplies    Aggregate of input price detail 
DOD-funded R&D  Federal obligations to intramural R&D by 
agency and by cost type. 
For 1972-2004, NIPA IPD for Federal 
defense installation support services.  For 
1951-1971, NIPA IPD for Federal defense 
services. 
DOE funded R&D  Federal obligations to intramural R&D by 
agency and by cost type. 
For 1972-2004, NIPA IPD for Federal 
defense services.  For 1951-1971, NIPA 
IPD for Federal defense weapons support 
services. 
HHS-funded R&D  Federal obligations to intramural R&D by 
agency and by cost type. 
For 1979-2004, NIPA unpublished 
biomedical R&D nonpersonnel price index. 
For 1951-78, extrapolated by NIPA price 
index for Federal nondefense intermediate 
goods and services purchased. 
NASA and other Federal agency 
funded R&D 
Federal obligations to intramural R&D by 
agency and by cost type. 
NIPA IPD for Federal nondefense 
intermediate goods and purchased services. 
CFC on R&D equipment    Aggregate of input price detail 
DOD-funded R&D  Perpetual inventory calculations at current 
cost based on gross investment and 
investment prices.  Gross investment for 
R&D equipment:  BEA estimate of small 
R&D equipment expenditures (6% of current 
Federal intramural expenses), which were 
removed from current expenses and 
reclassified as investment.  BEA estimate of 
large R&D equipment, which is included in 
NSF R&D plant expenditure data.  BEA 
assumes 15% of the plant expenditure total is 
for large equipment.   
NIPA price index for Federal national 
defense investment in equipment and 
software. 
DOE funded R&D  Perpetual inventory calculations at current 
cost based on gross investment and 
investment prices.  Gross investment for 
R&D equipment:  BEA estimate of small 
R&D equipment expenditures (6% of current 
Federal intramural expenses), which were 
removed from current expenses and 
reclassified as investment.  BEA estimate of 
large R&D equipment, which is included in 
NSF R&D plant expenditure data.  BEA 
assumes 15% of the plant expenditure total is 
for large equipment.   
NIPA price index for Federal national 
defense investment in equipment and 
software.  
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Table E. Input Price Indexes: Source Data and Methods for Cost Components and 
Corresponding Deflation 
Cost component  Data and methods for cost component  Method for deflation 
HHS-funded R&D  Perpetual inventory calculations at current 
cost based on gross investment and 
investment prices.  Gross investment for 
R&D equipment:  BEA estimate of small 
R&D equipment expenditures (6% of current 
Federal intramural expenses), which were 
removed from current expenses and 
reclassified as investment.  BEA estimate of 
large R&D equipment, which is included in 
NSF R&D plant expenditure data.  BEA 
assumes 15% of the plant expenditure total is 
for large equipment.   
NIPA price index for Federal national 
defense investment in equipment and 
software. 
NASA and other Federal agency 
funded R&D 
Perpetual inventory calculations at current 
cost based on gross investment and 
investment prices.  Gross investment for 
R&D equipment:  BEA estimate of small 
R&D equipment expenditures (6% of current 
Federal intramural expenses), which were 
removed from current expenses and 
reclassified as investment.  BEA estimate of 
large R&D equipment, which is included in 
NSF R&D plant expenditure data.  BEA 
assumes 15% of the plant expenditure total is 
for large equipment.   
NIPA chain-type price index for Federal 
nondefense investment in equipment and 
software. 
CFC on R&D Structures    Aggregate of input price detail 
DOD-funded R&D  Perpetual inventory calculations at current 
cost based on gross investment and on 
investment prices 
Gross investment for R&D structures:  
Federal obligations for Federal intramural 
plant less estimate of large equipment. 
NIPA price index for Federal national 
defense investment in industrial buildings. 
DOE funded R&D  Perpetual inventory calculations at current 
cost based on gross investment and on 
investment prices 
Gross investment for R&D structures:  
Federal obligations for Federal intramural 
plant less estimate of large equipment. 
NIPA chain-type price index for Federal 
national defense investment in industrial 
buildings. 
HHS-funded R&D  Perpetual inventory calculations at current 
cost based on gross investment and on 
investment prices 
Gross investment for R&D structures:  
Federal obligations for Federal intramural 
plant less estimate of large equipment. 
For 1997-2004, NIPA price index for 
Federal non-defense investment in new 
structures.  For 1951-1996, NIPA price 
index for Federal nondefense investment in 
industrial buildings. 
NASA and other Federal agency 
funded R&D 
Perpetual inventory calculations at current 
cost based on gross investment and on 
investment prices 
Gross investment for R&D structures:  
Federal obligations for Federal intramural 
plant less estimate of large equipment. 
For 1997-2004, NIPA price index for 
Federal non-defense investment in new 
structures.  For 1951-1996, NIPA price 
index for Federal nondefense investment in 
industrial buildings. 
State and local governments    Aggregate of input price detail  
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Table E. Input Price Indexes: Source Data and Methods for Cost Components and 
Corresponding Deflation 
Cost component  Data and methods for cost component  Method for deflation 
R&D expenditures excluding CFC  For years available from NSF (varied), R&D 
expenditures excluding R&D plant less BEA 
estimated research equipment.  For other 
years, interpolated or extrapolated by Federal 
obligations to state and local governments; 
non-Federal funding interpolated or 
extrapolated by NIPA state and local 
government consumption and gross 
investment estimates. 
NIPA IPD for "other" education and 
research and NIPA IPD for foundations and 
nonprofit research. 
CFC for structures and equipment  Perpetual inventory calculations at current 
cost, based on gross investment and on 
investment prices.  Gross investment for 
R&D structures and equipment:  Federal 
obligations on plant to state and local 
governments and BEA estimated research 
equipment expenditures, which were 
removed from current expenses and 
reclassified as investment. 
Direct valuation: Perpetual inventory 
calculations based on gross investment and 
on investment prices.  Investment prices:  
For equipment, the NIPA index for state 
and local fixed investment in equipment 
and software; for structures, the NIPA 
index for state and local fixed investment 
in health care structures. 
Public universities and colleges    Aggregate of input price detail 
R&D expenditures excluding CFC 
HHS-funded 
Estimate of HHS-funded R&D expenditures 
less research equipment expenditures, which 
were removed from current expenses and 
reclassified as investment.  Based on HHS 
R&D obligations to academic performers.  
For 1979-2004, NIPA unpublished 
biomedical R&D price index for academic 
grants and contracts.  For 1929-1978, 
extrapolated by NIPA personal 
consumption expenditures price index for 
"other" education and research. 
R&D expenditures excluding CFC 
non-HHS-funded 
R&D expenditures less research equipment 
expenditures, which were removed from 
current expenses and reclassified as 
investment with HHS funded portion 
removed.   
For 1960-95, academic R&D price index 
from the National Center for Education 
Statistics.  For other years, extrapolated by 
NIPA personal consumption expenditures 
price index for "other" education and 
research. 
CFC for structures  Perpetual inventory calculations at current 
cost, based on gross investment and on 
investment prices.  Gross investment for 
R&D structures:  Calculated as a percent of 
total NSF reported science and engineering 
space through 1989 then extrapolated to 2004 
based on federal plant obligations to 
academic R&D performers. 
Direct valuation: Perpetual inventory 
calculations based on gross investment and 
investment prices. 
Investment prices:  For structures, the 
NIPA price index for state and local 
government fixed investment in 
educational buildings. 
CFC for equipment  Perpetual inventory calculations at current 
cost, based on gross investment and on 
investment prices.  Gross investment for 
R&D large equipment:  Calculated as a 
percent of total science and engineering 
space.  For small equipment: NSF reported 
current fund research equipment 
expenditures, which were removed from 
current expenses and reclassified as 
investment. 
Direct valuation: Perpetual inventory 
calculations based on gross investment and 
investment prices. 
Investment prices:  For equipment, the 
NIPA price index for state and local 
government fixed investment in equipment 
and software. 
Federally funded research and 
development centers (FFRDCs) 
administered by public universities 
and colleges 
  Aggregate of input price detail 
DOD- and NASA-funded FFRDCs 
excluding CFC 
Expenditures for each FFRDC, aggregated 
by Federal sponsoring agency, less research 
equipment. 
NIPA price index for Federal defense 
purchases of R&D services.  
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Table E. Input Price Indexes: Source Data and Methods for Cost Components and 
Corresponding Deflation 
Cost component  Data and methods for cost component  Method for deflation 
DOE-funded FFRDCs and all other 
FFRDCs excluding CFC 
Expenditures for each FFRDC, aggregated 
by Federal sponsoring agency, less research 
equipment. 
NIPA unpublished price index for Federal 
nondefense purchases of R&D services. 
CFC for structures and equipment  Perpetual inventory calculations at current 
cost, based on gross investment and on 
investment prices.  Gross investment for 
R&D structures and equipment:  Federal 
obligations on plant to FFRDCs administered 
by public universities and colleges and BEA 
estimated research equipment expenditures, 
which were removed from current expenses 
and reclassified as investment.   
Direct valuation: Perpetual inventory 
calculations at current cost, based on gross 
investment and on investment prices.  
Investment prices:  For equipment, the 
NIPA index for public fixed investment in 
equipment and software by educational 
services industry (NAICS industry 61); for 
structures, the NIPA index for state and 
local fixed investment in educational 
buildings. 
BLS Bureau of Labor Statistics 
CFC Consumption of fixed capital 
DOD Department of Defense 
DOE Department of Energy 
HHS Department of Health and Human Services 
IPD Implicit price deflator     
KLEMS K-capital, L-labor, E-energy, M-materials, and S-purchased services; BEA production framework 
NASA National Aeronautics and Space Administration 
NAICS North American Industrial Classification system 
NIPA National Income and Product Accounts 
NSF National Science Foundation 
SIC Standard Industrial Classification system 
Note.  A Fisher chaining methodology used for aggregation of cost and sector detail. 
Chart A. Computer and Electrical  Mfg Gross Operating Surplus 
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Chart B. R&D Investment Price Index 
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1)  R&D Output, R&D Investment, and R&D Capital Stock 
 
  Diagram 1 provides a summary of three main aspects of R&D activity that need 
estimated prices, these are R&D output, R&D investment, and R&D capital stock.  The 
diagram also shows how they relate to each other. Solid arrows between the steps 
indicate market transactions, where prices are potentially available from economic survey 
data.  Dotted lines indicate uses that are internal to the firm and have no associated 
transaction data, or are transacted between parties without direct payment (cross-
licensing agreements). The left side of the diagram represents domestic transactions and 
the right side of the diagram represents cross-border transactions.  Because of their 
impact on GDP, more survey data are available for these transactions than for similar 
domestic ones.  
  The first box in the upper left corner represents the firm that produces R&D as 
economic output and represents the activity of the innovator.  Two things can happen to 
this output, the firm can sell it to another firm or the firm can retain it for its own use.  If 
the output is sold the transaction can be captured in economic survey data. These 
transactions for R&D can result in exports or domestic sales.  
 
  In the R&D satellite account, R&D output is treated as investment, because its use 
in production extends over several time periods and it produces an economic benefit to its 
owner.  The middle portion of the diagram represents the consumer of R&D output, 
where R&D is acquired as R&D as an investment good. It can be retained by its producer 
for own use, it can be purchased from another domestic firm, or it can be imported from  
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another country.  While a firm retaining R&D for its own use will be unobserved as a 
transaction, both domestic and international purchases of R&D are within the scope of 
existing survey data.  This R&D investment adds to the stock of R&D capital for 
business, government, and non-profit institutions serving households.  
 
  The lower portion of the diagram illustrates the uses of R&D capital stock held by 
business to generate an economic benefit.  There are three things that a firm can do with 
its R&D capital stock in a given time period: Hold for future use; use it in production; or 
sell it to some other entity.  If the firm sells part or all or its R&D capital stock, there is a 
market transaction that could produce a market value measure.   If the firm holds onto its 
R&D capital, either for future use or, if patented, to gain a strategic advantage in the 
market, the firm is gaining an economic benefit from the R&D capital, but this value will 
not be observed directly.  
 
   The R&D capital can also be used in production. The firm can license its 
patented or otherwise protected R&D assets out to other firms in exchange for royalties 
or licensing fees.  These are market transactions; survey data records international 
transactions of this type and domestic transactions of this type are recorded for a few 
industries.  The firm can cross-license its portfolio of R&D assets and related patents, 
allowing other firms access in exchange for access to their R&D assets and related 
patents.  In this case there may be no direct payment involved, or only a small net 
payment when one portfolio is substantially larger than the other.  Finally, the firm can 
use its R&D assets internally to create new products, improve old ones, or lower  
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production costs.  In this case there will be no observable price for the use of the R&D 
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Appendix Table A, Residual Intangible Asset Price Index, Aggregate Input Price Index, 
 
and Aggregate Output Price Index, 1987-2004 
    1 1992 1993 1994 1995  1987 1988 1989 1990 199
Residual R&D Price Indexes             
Chemical  manufacturing  /1/  24.1 28.1 34.2 41.4 48.2 53.7 58.6 65.3 73.4 
uct manufacturing /2/ 
  1 1 1
  127.5  100.9  5 8
laneous professional 
ustries, excluding Finance, Real Estate, 
33.2 35.5 39.0 42.2 45.8 50.9 58.4 64.9 72.2 
         
Computer and electronic prod 4.3  4.9  5.8  7.0  9.4  14.5  22.1  33.1  49.0 
Motor vehicle, body, trailer, and parts manufacturing 4.8  4.2  0.2  8.9  9.1  10.8 14.4 21.5  35.4 
Aerospace and other transportation manufacturing  /3/ 58.7  3.2  1.3 60.1 80.5 61.8 53.2 
Publishing,  including  software  33.1 35.2 38.3 40.0 41.9 45.1 49.2 53.3 57.0 
R&D Services and other Miscel
services 
Computer  Services 
41.0 45.7 52.0 58.9 64.5 70.4 75.1 78.6 80.3 
34.3 37.8 41.8 47.1 52.4 61.3 71.0 81.8 92.1 
All Other Private Ind
and Agriculture 
 
All Private Industries Indexes 
73.1 75.7 78.7 81.2 83.6 85.9 87.9 89.5 90.8 
Price  Index  123.4 125.5 127.1 126.9 128.4 127.4 127.0 126.3 122.9 
996  997  998  999  000  001  002  003 
         
Input  Price  Index 
Aggregate  Output 
           
   1 1 1 1 2 2 2 2 2004 
Residual R&D Price Indexes            
Chemical  manufacturing  /1/  81.2 90.6 98.6 01.9 00.0 98.8 99.3 02.5 12.5 
uct manufacturing /2/  1
 
  142.3 180.1 123.7 
126.7 
laneous professional 
84.1  88.7  92.9  96.9 100.0 101.9 104.0 110.0 120.0 
  Services  107.0 126.8 139.0 133.6 100.0 
ustries, excluding Finance, Real Estate, 
80.6  88.2  93.5  97.8 100.0 101.4 103.0 108.6 118.7 
        
1 1 1 1
Computer and electronic prod 71.6  98.6  17.0  118.7  100.0  67.1  33.5 23.5 20.0 
Motor vehicle, body, trailer, and parts manufacturing 63.9  85.0  94.9  96.1  100.0  87.0  80.5  59.5  44.3 
Aerospace and other transportation manufacturing /3/ 50.9  53.3 60.9 75.2  100.0  88.6 
Publishing,  including  software  64.5  72.2  80.1  93.4 100.0 104.6 110.7 119.3 
R&D Services and other Miscel
services 
Computer 67.0  44.8  33.0  28.1 
All Other Private Ind
and  Agriculture 
   
All Private Industries Indexes 
92.5  94.3  95.4  96.9 100.0 102.4 105.1 108.3  12.2 
 
cause they were undefined. Italic values w e. 
, 
NAICS 3365-
         
Aggregate  Input  Price  Index  1
Aggregate  Output  Price  Index 117 111 105 102 100  97  95.9  95.3  95.3 
Note: Bold values are imputed be ere imputed because they neighbored an undefined valu
/1/ Includes pharmaceuticals and medicine manufacturing (NAICS 3254), and chemicals minus pharmaceuticals manufacturing (NAICS 
325X). 
/2/ Includes computers and peripheral equipment manufacturing (NAICS 3341), communications equipment manufacturing (NAICS 3342)
semiconductor and other electronic components manufacturing (NAICS 3344), navigational, measuring, electro-medical, and control 
instruments manufacturing (NAICS 3345), and other computer and electronic products manufacturing (NAICS 3343, 3346). 
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Appendix Table B, Detailed
 
 Industry R&D Output Prices 
    1987 1988 1989 1990 1991 1992 1993 1994 1995 
            
Detailed Output Price Indexes      
51.6 55.5 60.3 65.4 70.5 75.2 78.3 80.7 83.1 
s 
t  808.2 749.6 702.4 636.1 575.9 498.6 425.3 384.6 327.7 
tronic  components 
83.3 85.6 88.6 91.2 93.9 95.6 96.9 97.8 99.1 
ucts  117.5 116.5 117.7 117.5 118.1 116.6 113.7 111.0 108.8 
ucts  and  parts 
  manufacturing 
302.4 269.0 224.1 195.4 185.8 149.0 142.0 129.8 122.9 
systems  design  and  related  services 
es 
         
      
Pharmaceuticals  and  medicines 
Chemicals  minus  pharmaceutical 74.9 81.1 85.2 85.2 86.5 86.3 87.5 90.0 97.0 
Computers  and  peripheral  equipmen
Communications  equipment  126.8 126.0 125.6 124.1 124.1 123.6 123.4 122.1 117.4 
Semiconductor  and  other  elec 565.4 573.2 554.4 507.0 481.0 442.7 416.9 383.9 304.5 
Navigational, measuring, electro-medical, and 
control  instruments  manufacturing 
Other  computer  and  electronic  prod
Motor vehicle, body, trailer, and parts 
manufacturing 
Aerospace  prod
84.7 86.2 88.6 90.1 92.6 94.8 96.9 99.1  100.2 
75.6 76.0 78.4 81.5 84.5 87.7 89.6 91.6 93.6 
Other  transportation  equipment 74.4 75.5 78.6 81.7 84.7 87.1 88.5 90.0 94.0 
Software 
Computer  74.4 77.4 78.4 80.7 83.3 84.4 86.2 87.7 91.2 
Scientific R&D services  62.8  66.2 68.7 71.2 74.4 76.6 78.1 79.7 83.3 
All  other  for-profit  industri 72.6 75.3 78.4 81.4 83.0 84.7 86.7 88.5 91.3 
 
 
Detailed Output Price Indexes  
996  997  998  1 1 1 1999 2000 2001 2002 2003 2004 
Pharmaceuticals  and  medicines  85.4  87.0  95.6  97.9 100.0 102.3 104.6 109.2 113.7 
Chemicals  minus  pharmaceuticals 
t  255.6  202.1  151.9  1
tronic components 
99.6 100.4 100.8 100.2 100.0 100.0 101.2 102.0 102.8 
ucts  1
101.1  100.5 99.5 99.7  100.0 99.5 98.3 98.2 99.3 
1 1 1 1
  manufacturing 
115.9  106.3  100.5 
systems design and related services  1
1 1 1
es 
96.7  97.5  94.2  93.6 100.0 100.0  99.0 104.3 111.5 
Computers  and  peripheral  equipmen 15.9  100.0 80.7 67.7 58.3 53.1 
Communications  equipment  115.7  114.7  109.8  105.2  100.0 95.9 91.9 87.3 82.6 
Semiconductor and other elec 237.5  200.5  152.8  125.2  100.0  79.7  77.8  73.1  69.4 
Navigational, measuring, electro-medical, and 
control instruments manufacturing 
Other  computer  and  electronic  prod 07.0  104.8  103.8  101.9  100.0 97.7 94.5 92.1 89.1 
Motor vehicle, body, trailer, and parts 
manufacturing 
Aerospace  products  and  parts  95.0  95.8  96.4  97.3 100.0  02.7  04.0  07.2  10.9 
Other  transportation  equipment 95.8  97.0  97.6  98.0 100.0 101.2 102.0 103.2 107.3 
Software  98.8  100.0 98.8 95.7 90.4 85.8 
Computer  93.4  96.7  94.9  96.8  100.0  00.9  99.7  98.3  96.7 
Scientific R&D services  85.9  88.5  91.4  95.2 100.0 103.9  07.7  13.1  19.3 
All  other  for-profit  industri 93.4  94.9  95.1  96.7 100.0 101.4 102.8 106.1 110.8 
 
 
 
 
 
 
 
 